These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 6499689

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Psychophysiological aspects of motion sickness.
    Murray JB.
    Percept Mot Skills; 1997 Dec; 85(3 Pt 2):1163-7. PubMed ID: 9450266
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. [Prevention of kinetosis in children. Transdermal therapy with scopolamine].
    Müller M, Besch W, Steilner D.
    Fortschr Med; 1987 Feb 10; 105(4):82, 86-7. PubMed ID: 3557264
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. The effects of dimenhydrinate, cinnarizine and transdermal scopolamine on performance.
    Gordon CR, Gonen A, Nachum Z, Doweck I, Spitzer O, Shupak A.
    J Psychopharmacol; 2001 Sep 10; 15(3):167-72. PubMed ID: 11565623
    [Abstract] [Full Text] [Related]

  • 30. The effects of TTS-scopolamine, dimenhydrinate, lidocaine, and tocainide on motion sickness, vertigo, and nystagmus.
    Pyykkö I, Padoan S, Schalén L, Lyttkens L, Magnusson M, Henriksson NG.
    Aviat Space Environ Med; 1985 Aug 10; 56(8):777-82. PubMed ID: 3929760
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Alleviation of induced vertigo. Therapy with transdermal scopolamine and oral meclizine.
    Schmitt LG, Shaw JE.
    Arch Otolaryngol Head Neck Surg; 1986 Jan 10; 112(1):88-91. PubMed ID: 3940518
    [Abstract] [Full Text] [Related]

  • 34. A reduction of vestibulo-visual integration during transdermally administered scopolamine and dimenhydrinate. A presentation of gain control theory in motion sickness.
    Pyykkö I, Schalén L, Jäntti V, Magnusson M.
    Acta Otolaryngol Suppl; 1984 Jan 10; 406():167-73. PubMed ID: 6332454
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Comparison between two anti-motion sickness drugs].
    Wang J, Qian JK, Wang BZ, Gao JY, Shi HZ.
    Space Med Med Eng (Beijing); 1999 Apr 10; 12(2):138-40. PubMed ID: 12430546
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.